NanOZ LNP-saRNA OVA
saRNA encoding OVA formulated in lipid nanoparticles
NanOZ LNP-saRNA OVA is a ready-to-use self-amplifying RNA (saRNA) encoding Ovalbumin (OVA), encapsulated in lipid nanoparticles (LNPs) produced by microfluidic technology. Ovalbumin is a commonly used antigen for immunization and biochemical studies and an established model allergen for airway hyper-responsiveness.
The LNPs are monodisperse, with a narrow size distribution and a high encapsulation efficiency (>80%). They are designed to protect the saRNA from degradation and to facilitate its intracellular uptake.
The saRNA is unmodified, capped at the 5' end (Cap1) and contains a poly(A) tail at the 3' end.
Concentration: 0.1 mg/mL (100 µg/mL) saRNA in LNPs
Buffer: PBS, 10% sucrose
Sizes:
- LNPSA30500: 0.5 mL (2 x 250 µL)
- LNPSA31000: 1 mL (4 x 250 µL)
- LNPSA35000: 5 mL (20 x 250 µL)
Storage: -80°C. We recommend minimizing freeze-thaw cycles to preserve LNP integrity.
Shipping: Dry ice (dry ice fee included in shipping cost).
This product is manufactured "on demand", which means that no stock is produced, so the expected delivery time is 2 to 3 weeks.
| Catalog number | Unit Size | Price excl tax | Quantity / Buy |
| LNPSA30500 |
0.5 mL (2 × 250 µL) of saRNA-LNP, 50 µg of OVA saRNA
|
$900.00
|
|
| LNPSA31000 |
1 mL (4 × 250 µL) of saRNA-LNP, 100 µg of OVA saRNA
|
$1,582.00
|
|
| LNPSA35000 |
5 mL (20 × 250 µL) of saRNA-LNP, 500 µg of OVA saRNA
|
$6,076.00
|
|
Citation database
Related products
OVA saRNA
Vaccine/Antigen saRNA
Unmodified / m5C
NanOZ LNP-saRNA GFP
NanOZ LNP-saRNA
saRNA encoding eGFP formulated in lipid nanoparticles
NanOZ LNP-saRNA FLuc
NanOZ LNP-saRNA
saRNA encoding FLuc formulated in lipid nanoparticles